Global CRISPR & Cas Genes Market Opportunities and Forecast 2023-2030

CRISPR & Cas Genes Market Overview

CRISPR-Cas systems are efficient and easily programmable nucleic acid-targeting tools, with uses reaching beyond research and therapeutic development into the precision breeding of plants and animals and the engineering of industrial microbes. CRISPR-Cas systems have the potential for many microbial engineering applications, including bacterial strain typing, immunization of cultures, autoimmunity or self-targeted cell killing, and the engineering or control of metabolic pathways for improved biochemical synthesis. 

Several factors are significantly expanding the growth of the global CRISPR & Cas Genes market in the next few years. Increasing incidence of genetic disorders and rising government spending on research and development of genome editing majorly contribute to the growth of the market. Additionally, the usage of CRISPR-Cas systems in bacteria and usage of CRISPR/Cas9 technology to improve crop production are further boosting the growth of the global CRISPR and Cas genes market. In addition to this, the application of CRISPR/Cas9 focusing on somatic cell genome editing programs is intended at accelerating the use of these technologies to treat various genetic disorders.

On the other hand, ethical issues concerning CRISPR and the lack of skilled professionals hamper the growth of the global CRISPR and Cas genes market.

Covid-19 Impact on CRISPR & Cas Genes Market:

In addition, the current CRISPR & Cas Genes Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the CRISPR & Cas Genes Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

CRISPR & Cas Genes Market Segment Overview

According to the product, the Vector-Based Cas segment has the largest share of the global market. Vector-based Cas expression systems are beneficial for researchers who focus on enriching Cas9-expressing cells or try to establish a stable cell line. In addition, Vector-based Cas is also available with an inducible promoter that helps the formation of stable cell lines with minimal background expression, or for temporal control over Cas9 expression for extensive experimental applications.

Based on application, the genome engineering segment has significant growth in the market. CRISPR technology allows genetic material to be added, removed, or altered at specific locations in the genome. Cas9 mRNA or purified Cas9 protein is the source for Cas9 nuclease expression in genome engineering experiments. As well, genomic engineering is the synthetic assembly of complete chromosomal DNA that is more or less derived from natural genomic sequences.

CRISPR & Cas Genes Market, By Product

·       Vector-Based Cas 
·       DNA-free Cas

CRISPR & Cas Genes Market, By Application

·       Genome Engineering
·       Disease Models
·       Functional Genomics
·       Knockout/Activation
·       Others

CRISPR & Cas Genes Market, By End-User

·       Biotechnology & Pharmaceutical Companies
·       Academic & Government Research Institutes
·       Contract Research Organizations

CRISPR & Cas Genes Regional Overview

In terms of region, North America dominated the global CRISPR and Cas genes market. This can be attributed to the rising research activities and technological advancements in this region. Similarly, Europe is the prominent region for the CRISPR and Cas genes market. The increasing adoption of technology and the presence of key players are expected to boost the growth of the market in this region. Likewise, The market of the Asia Pacific is projected to grow at the fastest rate owing to the increasing number of ongoing clinical trials and expanding research in gene editing tools in the region. Also, the growing popularity of CRISPR technology in Asian countries such as China and Japan is projected to further support the growth of the market in this region.

CRISPR & Cas Genes Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

CRISPR & Cas Genes Market, Key Players

·       Synthego
·       Thermo Fisher Scientific, Inc.
·       GenScript
·       Addgene
·       Merck KGaA (Sigma-Aldrich)
·       Integrated DNA Technologies, Inc.
·       Transposagen Biopharmaceuticals, Inc.
·       OriGene Technologies, Inc.
·       New England Biolabs
·       Dharmacon
·       Cellecta, Inc.
·       Agilent Technologies
·       Applied StemCell, Inc.